Christian Mandl

Christian W Mandl, PhD, MD has a wealth of experience in the field of virology and vaccine development. With a background in medicine, biochemistry, and virology, Christian has held various leadership positions in both academic and industry settings. Currently, Christian serves as a Consultant at Vaccines and Viral Vectors, Co-Founder and Chief Scientific Officer at Tiba Biotech, Chair of the Scientific Advisory Group at the International Vaccine Institute, Senior Advisor at Adjuvant Capital, and Co-Founder and Chief Scientific Officer at Accurius. Their work focuses on developing innovative approaches for vaccine development and RNA medicine. Christian's expertise and leadership have been instrumental in advancing research and development in the field of virology and infectious diseases.